Call your healthcare professional immediately or seek emergency medical attention if you develop unusual or serious symptoms after taking Linzess, such as: Severe abdominal pain Bloody or black stools Dizziness or fainting Signs of dehydration (excessive thirst, dry mouth, sunken eyes, fast heartbeat) Severe allergic reaction (skin rash, hives, itching, swelling of the lips, tongue, or throat, difficulty breathing) Rare but serious risks of taking Linzess include: Dehydration: Linzess should never be given to children younger than 2 years of age because it can cause life-threatening serious dehydration (loss of body fluids) in very young children
Benefits: Dual Action: Targets both GIP and GLP-1 receptors for enhanced effectiveness
Regarding the efficacy of oral lipoic acid supplementation, an initial short-term study in 24 patients with type 2 diabetes mellitus found that the symptoms of peripheral neuropathy improved in those who took 600 mg of lipoic acid three times a day for three weeks compared to those who took a placebo (75)
The GLP-1 peptide (a short chain of amino acids) is secreted by cells in the small intestine, but it is also synthesized in the brain